Your browser doesn't support javascript.
loading
Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.
DeNardo, Sally J; Richman, Carol M; Albrecht, Huguette; Burke, Patricia A; Natarajan, Arut; Yuan, Aina; Gregg, Jeff P; O'Donnell, R T; DeNardo, Gerald L.
  • DeNardo SJ; School of Medicine, University of California Davis, Sacramento, California 95816, USA. sjdenardo@ucdavis.edu
Clin Cancer Res ; 11(19 Pt 2): 7187s-7194s, 2005 Oct 01.
Article en En | MEDLINE | ID: mdl-16203820
Search on Google
Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioinmunoterapia Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male Idioma: En Año: 2005 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioinmunoterapia Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male Idioma: En Año: 2005 Tipo del documento: Article